Washington D.C. – August 11, 2026 – In a monumental victory for the epilepsy community, the U.S. Senate unanimously passed the National Plan for Epilepsy Act (S. 494) on August 4, 2026. This historic legislative action marks a pivotal step towards establishing a comprehensive, coordinated national strategy aimed at fundamentally transforming epilepsy care, accelerating research breakthroughs, significantly reducing epilepsy-related mortality, and profoundly enhancing the quality of life for the estimated 3.4 million Americans currently living with the condition.
n
The unanimous vote, announced with fervent celebration by Epilepsy Alliance America on August 11, reflects years of tireless advocacy and bipartisan cooperation. It signals a growing recognition within the nation’s highest legislative body of the urgent need to address the complex challenges posed by epilepsy, a neurological disorder characterized by recurrent, unprovoked seizures. The Act, now advancing to the House of Representatives, promises a unified federal approach to a condition that has long impacted individuals and families across the country, often with insufficient and fragmented support.
n
A Historic Breakthrough for Epilepsy Care: Senate Unanimously Passes National Plan Act
n
The National Plan for Epilepsy Act (S. 494) is not merely a legislative formality; it represents a paradigm shift in how the United States approaches epilepsy. Its unanimous passage through the Senate on August 4, 2026, culminating in an announcement by Epilepsy Alliance America a week later, sent a wave of hope and relief through a community that has long championed such a coordinated effort. The Act’s core purpose is to mandate the federal government to review its existing epilepsy programs, meticulously identify critical gaps in services and patient outcomes, and subsequently develop actionable recommendations to address these unmet needs.
n
At its heart, the legislation aims to foster a cohesive national strategy encompassing several vital pillars: advancing cutting-edge research to better understand the causes and mechanisms of epilepsy, improving diagnostic tools and treatment protocols, raising public awareness to combat pervasive stigma, implementing robust mortality prevention measures, and ultimately, elevating the overall quality of life for individuals navigating the complexities of epilepsy. This holistic approach is designed to move beyond fragmented initiatives, creating a streamlined and effective framework that leverages national resources and expertise.
n
The bill’s journey through the Senate was championed by the bipartisan leadership of Senators Eric Schmitt and Amy Klobuchar, whose dedication to improving the lives of people affected by epilepsy proved instrumental in securing broad support. Their collaborative effort underscores the non-partisan nature of health crises and the shared commitment to finding solutions that transcend political divides. The passage of S. 494 is a testament to the power of persistent advocacy, demonstrating that when a community speaks with a unified voice, legislative change is not only possible but inevitable. This significant achievement is the culmination of years of dedicated work by an expansive network of individuals, including people with lived experience of epilepsy, their families, tireless caregivers, front-line healthcare professionals, pioneering researchers, and numerous epilepsy organizations nationwide, all working tirelessly to elevate the needs and voices of the epilepsy community onto the national stage. Their collective efforts have laid the groundwork for what promises to be a transformative era in epilepsy care and support.
n
The Journey to a National Strategy: A Chronology of Advocacy and Legislative Action
n
The unanimous Senate passage of the National Plan for Epilepsy Act did not happen overnight; it is the culmination of a protracted and deeply personal journey spanning many years, marked by unwavering advocacy and strategic legislative engagement. For decades, the epilepsy community has grappled with a fragmented landscape of care, research, and awareness initiatives. This inherent lack of coordination often left individuals and families feeling isolated, struggling to navigate a complex system without a cohesive national framework. The recognition of this systemic challenge ignited the spark for a national plan, an idea nurtured and championed by an ever-growing coalition.
n
The early stages of this movement were defined by what Epilepsy Alliance America describes as "years of dedicated advocacy." This involved countless individuals with epilepsy, their families, and caregivers sharing their personal stories – tales of resilience, struggle, and the profound impact of the condition on daily life. These narratives formed the emotional bedrock of the advocacy, bringing the abstract concept of epilepsy into vivid, human terms for policymakers. Healthcare professionals, from neurologists to specialized nurses, contributed their clinical insights, highlighting the medical complexities and the urgent need for advanced research and improved treatment access. Researchers, meanwhile, underscored the scientific frontiers yet to be explored, advocating for increased funding and coordinated efforts to unlock new diagnostics and therapies. Epilepsy organizations across the country played a crucial role in mobilizing these diverse voices, consolidating disparate efforts into a unified, powerful movement.
n
A significant turning point in the legislative process occurred on July 22, 2026, when the Senate Health, Education, Labor and Pensions (HELP) Committee approved a Manager’s Amendment to S. 494. This amendment was critical; it not only preserved the bill’s core purpose – to establish a comprehensive national plan – but also strengthened its underlying framework, ensuring that the eventual plan would be robust, inclusive, and effective. Such an amendment typically refines the bill’s language, clarifies mandates, and often incorporates feedback from various stakeholders to enhance its viability and impact. This committee approval signaled serious legislative intent and momentum, paving the way for a full Senate vote.
n
The momentum continued to build, culminating in the historic vote on August 4, 2026, when the U.S. Senate unanimously passed the National Plan for Epilepsy Act. This overwhelming support was a powerful affirmation of the broad consensus that a national strategy is not just beneficial, but essential. It underscored the effectiveness of the "grassroots advocacy" that defined the movement. Thousands of advocates nationwide actively participated in a myriad of ways: they contacted their elected officials through letters, emails, and phone calls; they participated in crucial meetings with congressional staff, articulating the real-world implications of epilepsy; they signed support letters that demonstrated collective resolve; and they tirelessly raised awareness about the urgent need for a coordinated national epilepsy strategy through public campaigns and community outreach.
n
Further illustrating the collaborative spirit, earlier in the year, a specialized committee, which included Epilepsy Alliance America Board member Amanda Mitchell, MPH, drafted "The Epilepsy Community Consensus Priorities." These priorities served as a foundational document, meticulously outlining the key areas where a national plan could make the most significant difference, such as comprehensive research agendas, equitable access to specialized care, enhanced support services, and effective public education campaigns. This consensus-driven approach ensured that the legislative effort was deeply rooted in the lived experiences and expert insights of the epilepsy community itself. The journey from initial advocacy to Senate passage is a testament to the enduring power of persistent, unified action in shaping national policy.
n
Unpacking the National Plan: Supporting Data and the Scope of the Challenge
n
The urgent need for the National Plan for Epilepsy Act is underscored by compelling data that reveal the significant prevalence, profound impact, and substantial economic burden of epilepsy in the United States. Far from being a rare condition, epilepsy affects a vast segment of the American population, often with devastating consequences that extend far beyond the immediate experience of seizures.
n
Prevalence and Demographics: According to estimates from leading health organizations like the Centers for Disease Control and Prevention (CDC) and the Epilepsy Foundation, over 3.4 million Americans are currently living with active epilepsy. This means that approximately 1 in 26 people will develop epilepsy at some point in their lives, making it one of the most common neurological disorders. The condition affects individuals across all age groups, genders, races, and socioeconomic backgrounds, from infants to the elderly. Alarmingly, incidence rates are often highest in young children and older adults, presenting distinct challenges in diagnosis, treatment, and ongoing care for these vulnerable populations.
n
Impact Beyond Seizures: The ramifications of epilepsy extend far beyond the visible manifestation of seizures. Individuals living with epilepsy frequently contend with a complex array of co-occurring conditions and challenges. Cognitive impairments, including memory issues and difficulties with concentration, are common. Mental health comorbidities, such as depression and anxiety, are also significantly higher among people with epilepsy compared to the general population, often exacerbated by the unpredictability of seizures and the social stigma associated with the condition. The constant threat of a seizure can lead to limitations in daily activities, affecting independence, driving privileges, and even social interactions, leading to isolation.
n
Mortality and SUDEP: One of the most critical and often overlooked aspects of epilepsy is its association with increased mortality. The National Plan for Epilepsy Act explicitly aims to "reduce epilepsy-related deaths," addressing a stark reality. People with epilepsy have a mortality rate two to three times higher than the general population. A significant concern is Sudden Unexpected Death in Epilepsy (SUDEP), which is the leading cause of death in people with uncontrolled epilepsy. While the exact mechanisms of SUDEP are still being researched, it is estimated to affect about 1 in 1,000 adults with epilepsy each year. Beyond SUDEP, epilepsy-related deaths can also result from prolonged seizures (status epilepticus), accidents during seizures, or complications from underlying conditions. Enhanced awareness, better seizure control, and targeted research are vital to mitigate these risks.
n
Gaps in Care and Research: The bill’s mandate to "identify gaps in services and outcomes" is crucial, as significant disparities exist in epilepsy care. Many individuals, particularly those in rural or underserved areas, lack access to specialized neurologists or comprehensive epilepsy centers, which offer advanced diagnostic tools and treatment options. There’s also a notable lack of awareness and education about epilepsy among primary care physicians, leading to delayed or misdiagnoses. Furthermore, research funding for epilepsy, while growing, has historically lagged behind that of other neurological conditions, hindering the discovery of new anti-seizure medications, non-pharmacological interventions, and ultimately, cures. There’s a particular need for research into the causes of epilepsy, personalized medicine approaches, and strategies to prevent SUDEP.
n
Stigma and Quality of Life: The social stigma surrounding epilepsy remains a formidable barrier, impacting individuals’ self-esteem, employment opportunities, and social acceptance. Misconceptions about epilepsy can lead to discrimination in workplaces, schools, and public settings, contributing to feelings of shame and isolation. This stigma, combined with the unpredictable nature of seizures and potential side effects of medications, severely diminishes the quality of life for many. Challenges in employment, maintaining stable relationships, and participating fully in community life are common. The National Plan’s focus on "awareness" and "quality of life" directly addresses these profound societal and personal burdens, aiming to create a more informed, empathetic, and supportive environment.
n
Economic Burden: The economic impact of epilepsy on the U.S. healthcare system and economy is substantial. Estimates suggest the annual economic burden, encompassing direct medical costs (hospitalizations, medications, doctor visits), lost productivity due to disability or premature mortality, and indirect costs (caregiver burden, lost wages), runs into tens of billions of dollars. A coordinated national strategy that improves diagnosis, optimizes treatment, and reduces complications could lead to significant long-term cost savings by minimizing acute care interventions and enhancing workforce participation.
n
In essence, the data paints a clear picture: epilepsy is a pervasive, complex, and costly condition that necessitates a unified national response. The National Plan for Epilepsy Act provides the framework to address these multifaceted challenges head-on, promising a future where individuals with epilepsy receive the comprehensive care, support, and scientific innovation they so desperately need and deserve.
n
Voices of Commitment: Official Responses and Community Resolve
n
The unanimous Senate passage of the National Plan for Epilepsy Act was met with a wave of gratitude and renewed determination from the epilepsy community, whose leaders articulated both the significance of the achievement and the critical work that lies ahead. Their collective responses underscore a deep-seated commitment to seeing this plan fully enacted and implemented.
n
Liza Gundell, Board Chair of Epilepsy Alliance America, expressed profound appreciation for the legislative champions, stating, "We are grateful to Senators Eric Schmitt and Amy Klobuchar for their bipartisan leadership and commitment to improving the lives of people affected by epilepsy. The Senate’s unanimous support demonstrates a growing recognition that epilepsy deserves a coordinated national response." Gundell further emphasized the multifaceted challenges faced by those living with the condition, elaborating, "For too many individuals and families, epilepsy brings challenges that extend far beyond seizures, including barriers to care, stigma, financial burdens, and concerns about safety and quality of life. A National Plan for Epilepsy will help ensure that these challenges are addressed through a thoughtful, comprehensive, and collaborative strategy." Her statement highlights the holistic vision behind the Act, recognizing that effective support must encompass medical, social, and economic dimensions to truly improve patient outcomes.
n
While celebrating the monumental step, Lisa Gallipoli, Executive Director of Epilepsy Alliance America, issued a rallying cry, reminding the community that the journey is far from over. "The passage by the Senate of the National Plan for Epilepsy is a great achievement; but our work is not done!," Gallipoli declared. Her powerful emphasis underscores the strategic imperative of securing passage in the House of Representatives. She continued, "Epilepsy Alliance America is proud to be part of the greater epilepsy community, speaking and acting in one shared voice, about the National Plan for Epilepsy. We will continue to mobilize our network to ensure that the House of Representatives follows the lead of the Senate before the end of the Congressional term." Gallipoli’s remarks reflect the enduring spirit of collaboration and the strategic focus required to navigate the remaining legislative hurdles, stressing the power of collective action.
n
Perhaps most poignantly, Amanda Mitchell, MPH, an Epilepsy Alliance America Board member and a key member of the National Plan for Epilepsy Committee, offered a deeply personal perspective as the parent of a child with epilepsy. "As the parent of a child with epilepsy, advocating for the National Plan for Epilepsy is deeply personal to me," Mitchell shared. Her lived experience lends powerful authenticity to the advocacy efforts, resonating with countless families across the nation. She articulated the urgent needs of the community, stating, "I know just how desperately our community needs the investments in comprehensive research, effective treatments, improved access to care, and increased support. It has been a privilege to add my voice to those in the epilepsy community who have pushed for this change for many years. I look forward to continuing to support this work until the plan is enacted into law, and we see its benefits for the millions of Americans living with epilepsy." Mitchell’s words encapsulate the profound hope and determination that fuel the advocacy movement, emphasizing the tangible benefits that the plan promises to deliver to real lives.
n
Collectively, these statements reveal a community that is profoundly grateful for the progress achieved but remains steadfast in its resolve. There is a clear understanding that while Senate passage is a historic milestone, it is merely a crucial step towards the ultimate goal: the full enactment and subsequent implementation of a national strategy that will fundamentally improve the landscape of epilepsy care, research, and support in the United States. The unified voice of commitment from these leaders serves as both a celebration and a renewed pledge to continue the fight.
n
The Road Ahead: Implications and Call to Action
n
The unanimous passage of the National Plan for Epilepsy Act (S. 494) by the U.S. Senate carries significant immediate and long-term implications for the millions of Americans affected by epilepsy. While the battle is not yet won, this legislative achievement represents a powerful validation of the community’s advocacy and sets a strong precedent for future action.
n
Immediate Implications:
The Senate’s overwhelming support injects tremendous momentum into the legislative process. It sends a clear signal to the House of Representatives that a national consensus exists regarding the necessity of this plan. This bipartisan endorsement from the Senate enhances the bill’s legitimacy and increases its chances of swift consideration and passage in the House before the close of the current congressional term. It also elevates the visibility of epilepsy on the national health agenda, drawing attention to a condition that has often been overlooked or misunderstood.
Long-Term Implications (Upon Enactment):
Should the National Plan for Epilepsy Act be signed into law, its impact would be transformative:
- Coordinated Federal Approach: The most profound implication is the shift from fragmented, often isolated initiatives to a cohesive, strategically coordinated federal response. This would ensure that resources are allocated efficiently, efforts are streamlined, and a clear national vision guides all epilepsy-related programs across various federal agencies.
- Improved Patient Outcomes: A national strategy focused on diagnosis, treatment, and access to care promises better health outcomes for individuals with epilepsy. This could mean earlier diagnosis, more effective seizure management, improved access to specialized epilepsy centers and neurologists, and a reduction in complications.
- Accelerated Research and Innovation: By requiring the identification of research gaps and the development of recommendations, the Act is poised to accelerate scientific inquiry. This could lead to increased funding for novel treatments, preventative strategies, a deeper understanding of epilepsy’s causes, and ultimately, the pursuit of a cure.
- Reduced Mortality: The explicit focus on mortality prevention, including initiatives related to SUDEP, holds the potential to save lives. Enhanced awareness among patients and healthcare providers, alongside targeted research, could significantly reduce the incidence of epilepsy-related deaths.
- Enhanced Quality of Life and Reduced Stigma: A national plan would likely include robust public awareness campaigns designed to educate the public, dispel myths, and combat the pervasive stigma associated with epilepsy. This, combined with improved access to support services and better seizure control, could dramatically enhance the social, emotional, and economic quality of life for individuals and their families.
- Data-Driven Policy: By mandating the review of existing programs and the identification of service gaps, the Act ensures that future policies and resource allocations will be based on evidence and actual community needs, rather than assumptions.
- Precedent for Other Conditions: The successful establishment of a national plan for epilepsy could serve as a valuable model for addressing other complex neurological or chronic conditions that currently lack a cohesive national strategy.
Challenges Ahead:
Despite the strong Senate vote, challenges remain. The bill must still navigate the House of Representatives, where it will require dedicated advocacy to ensure it moves through committees and onto the floor for a vote. Securing consistent funding for the initiatives outlined in the plan will also be a continuous effort, requiring sustained congressional support.
Next Steps for Advocacy:
Epilepsy Alliance America, alongside its partners, is already focused on the next critical phase: securing passage in the House. They are working closely with congressional champions, including Representatives Jim Costa (CA-21) and Greg Murphy, M.D. (NC-3), to build support and ensure the bill’s successful passage before the end of the year.
The organization emphasizes that while momentum is building, the work is far from finished. The collective voice of the epilepsy community remains vital. Epilepsy Alliance America strongly encourages every individual impacted by epilepsy, along with their allies, to take immediate action:
Contact your U.S. Representative and urge them to co-sponsor and support the National Plan for Epilepsy Act.
This crucial advocacy will ensure that the historic progress achieved in the Senate translates into a definitive legislative victory, ushering in a new era of hope and improved outcomes for millions of Americans living with epilepsy. The time for a coordinated national response is now, and the community’s continued engagement is paramount to making this vision a reality.
